A 33-year-old man with ileal Crohn's disease (Montreal classification A2, L1, B1) under adalimumab therapy presented to the emergency room with mesogastric abdominal pain, diarrhea, and vomiting during the previous 4 weeks. Physical examination showed no abdominal masses or peritoneal signs. Initial blood tests demonstrated leukocytosis and an increase of C-reactive protein. Abdominal computed tomography (CT) revealed a long segment of distal ileum, containing inflammatory stricturing disease and a radiopaque calcium-density foreign body, compatible with a mollusc shell (▶ Fig. 1 ). Conservative management was initiated with antibiotics, intravenous corticosteroids, and fasting, increasing oral intake progressively. The symptoms markedly improved but a repeat CT scan 7 days later showed persistence of the shell. Consequently, the patient underwent retrograde single-balloon enteroscopy (Olympus Medical, Tokyo, Japan) for the endoscopic removal of the shell. Endoscopic findings in the distal ileal mucosa included intense edema, longitudinal deep ulcers, and small aphthous erosions. At approximately 30 cm proximal to the ileocecal valve, a 20-mm shell was visualized, causing partial luminal occlusion (▶ Fig. 2 a) . The foreign body was anchored to the ulcerated ileal mucosa and was extracted successfully using a rat-tooth forceps without any complication (▶ Fig. 2 b, ▶ Video 1) . Symptoms improved immediately after shell removal (▶ Fig. 3) , and the patient could be discharged after anal enteroscopy. Therapeutic single-balloon enteroscopy can avoid the need for surgery in patients with Crohn's disease and intestinal obstruction due to a retained foreign body [1 -3] . The optimization of medical and endoscopic treatment avoided an ileocecal resection in an intensely active ileal Crohn's disease.
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▶ Fig. 1 Initial computed tomography (CT) scan. a Sagittal view showed a hyperintense foreign body, suggestive of a mollusc shell, retained in the thickened wall of the distal ileum (red arrow). b CT with 3 D reconstruction showed a mollusc shell in an intra-abdominal location (red arrow).
